glp-1 compound Compounded - Semaglutide & Tirzepatide Compounded GLP-1 Training & Drug
Description
planned combo with YP05002 a unique differentiator vs Lilly and Novo
GLP-1 drugs are quickly becoming some of the most ubiquitous in the U.S., and they have drawn interest for their potential use in treating alcohol use disorder.
sales of GLP-1 drugs were $13.7 billion.
Insurance plans place GLP-1 drugs into different coverage tiers, often requiring prior authorization or high out-of-pocket costs
Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 trial results demonstrating 25% weight loss in half of people with #obesity
